Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy.

Douglas W Blayney,Nicole M Kuderer, Alice Kate Cummings Joyner, John Jarvis, Dominic Nunag,Jasmine Wells,Lan Huang,Ramon Monhanlal,Gary H Lyman

Journal of the National Comprehensive Cancer Network : JNCCN（2023）

引用 0|浏览4

暂无评分

摘要

Overall, the rates of chemotherapy-related FN and infection in week 1 of the first chemotherapy cycle are similar for patients receiving and not receiving G-CSF, suggesting continued risk in week 1 despite prophylactic G-CSF.

查看译文

关键词

febrile neutropenia,prophylactic growth factor use,chemotherapy,growth factor,real-world,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要